Log in

NYSE:PBHPrestige Consumer Healthcare Stock Price, Forecast & News

$36.28
+0.11 (+0.30 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$35.68
Now: $36.28
$36.66
50-Day Range
$36.17
MA: $40.11
$44.07
52-Week Range
$27.40
Now: $36.28
$46.12
Volume390,900 shs
Average Volume526,938 shs
Market Capitalization$1.82 billion
P/E Ratio13.05
Dividend YieldN/A
Beta0.8
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Read More
Prestige Consumer Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.1Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.76 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
CUSIP74112D10
Phone914-524-6800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$963.01 million
Cash Flow$3.68 per share
Book Value$23.30 per share

Profitability

Net Income$142.28 million

Miscellaneous

Employees530
Market Cap$1.82 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

How has Prestige Consumer Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PBH stock has increased by 1.0% and is now trading at $36.28. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Prestige Consumer Healthcare?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Prestige Consumer Healthcare.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Prestige Consumer Healthcare.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) announced its quarterly earnings data on Thursday, May, 7th. The company reported $0.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.74 by $0.08. The business had revenue of $251.20 million for the quarter, compared to analysts' expectations of $239.65 million. Prestige Consumer Healthcare had a return on equity of 13.33% and a net margin of 14.77%. The company's quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.72 earnings per share. View Prestige Consumer Healthcare's earnings history.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare issued an update on its first quarter earnings guidance on Thursday, May, 7th. The company provided EPS guidance of $0.70 or more for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.69. The company issued revenue guidance of ~$220 million or more, compared to the consensus revenue estimate of $232.21 million.

What price target have analysts set for PBH?

7 Wall Street analysts have issued twelve-month price objectives for Prestige Consumer Healthcare's stock. Their forecasts range from $43.00 to $91.00. On average, they anticipate Prestige Consumer Healthcare's stock price to reach $66.83 in the next year. This suggests a possible upside of 84.2% from the stock's current price. View analysts' price targets for Prestige Consumer Healthcare.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

Headlines about PBH stock have been trending negative recently, according to InfoTrie. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Prestige Consumer Healthcare earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Prestige Consumer Healthcare.

Are investors shorting Prestige Consumer Healthcare?

Prestige Consumer Healthcare saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 4,880,000 shares, an increase of 22.6% from the June 15th total of 3,980,000 shares. Based on an average daily volume of 476,100 shares, the short-interest ratio is presently 10.2 days. Currently, 9.8% of the company's stock are short sold. View Prestige Consumer Healthcare's Current Options Chain.

Who are some of Prestige Consumer Healthcare's key competitors?

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Gilead Sciences (GILD), AbbVie (ABBV), GW Pharmaceuticals PLC- (GWPH), Johnson & Johnson (JNJ), TG Therapeutics (TGTX), Flexion Therapeutics (FLXN), Marathon Petroleum (MPC), Pfizer (PFE), AT&T (T) and Thermo Fisher Scientific (TMO).

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the following people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)
  • Ms. Christine Sacco, Chief Financial Officer (Age 43)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)
  • Mr. Jeff Zerillo, Sr. VP of Operations

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Skyline Asset Management LP (0.18%) and Diversified Trust Co (0.03%). Company insiders that own Prestige Consumer Healthcare stock include Paton Brett, Ronald M Lombardi and Timothy Connors. View institutional ownership trends for Prestige Consumer Healthcare.

Which major investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including Skyline Asset Management LP. View insider buying and selling activity for Prestige Consumer Healthcare.

Which major investors are buying Prestige Consumer Healthcare stock?

PBH stock was bought by a variety of institutional investors in the last quarter, including Diversified Trust Co. View insider buying and selling activity for Prestige Consumer Healthcare.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $36.28.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $1.82 billion and generates $963.01 million in revenue each year. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is www.prestigebrands.com.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.